New episode is up, but only for subs rn.
Niklas Anzinger has spent the last few years building a biotech hub inside Próspera. In this conversation he makes the case that the FDA's monopoly on who gets to try what medicine is costing lives, and that the cracks are finally appearing.
Dog cancer vaccines built at home for $3,000 with AlphaFold.
Sid Sijbrandij going founder mode on his own bone cancer.
China eating 30% of global pharma licensing deals in a decade.
Montana and New Hampshire quietly cracking open the Right to Try framework.
And why Próspera's insurance-based regulatory model might be the most important governance innovation nobody's talking about.
Early access on @Fountain now. General release Friday at 6.15am GMT.
https://fountain.fm/episode/d0sQp6idoayM1GrrVXHx
Niklas Anzinger has spent the last few years building a biotech hub inside Próspera. In this conversation he makes the case that the FDA's monopoly on who gets to try what medicine is costing lives, and that the cracks are finally appearing.
Dog cancer vaccines built at home for $3,000 with AlphaFold.
Sid Sijbrandij going founder mode on his own bone cancer.
China eating 30% of global pharma licensing deals in a decade.
Montana and New Hampshire quietly cracking open the Right to Try framework.
And why Próspera's insurance-based regulatory model might be the most important governance innovation nobody's talking about.
Early access on @Fountain now. General release Friday at 6.15am GMT.
https://fountain.fm/episode/d0sQp6idoayM1GrrVXHx
22❤️2👍1
